Plain-English translation of NCT06549062 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Researchers want to understand how the body processes acetaminophen (a common over-the-counter pain reliever) differently in people with obesity compared to people without obesity. The study will give participants intravenous acetaminophen during surgery and measure how much medication reaches their bloodstream and what byproducts the body creates. This information could help doctors figure out if people with obesity need different doses to get the same pain relief.
Current pain-relief guidelines recommend the same acetaminophen dose for everyone, but recent research suggests people with obesity may need higher doses to feel the same effect. At the same time, the body might create more potentially harmful byproducts. This trial will gather the evidence needed to determine if dosing guidelines should change for people with obesity.
If you qualify, you will receive acetaminophen intravenously during your scheduled surgery as part of your normal pain management. Researchers will collect small blood samples from your vein and fingertip (using a minimally invasive method) after your first dose and again after several doses to measure how much medication is in your bloodstream and what byproducts your body creates. The blood draws are in addition to routine surgical care, and participation ends after your surgery.
AI-generated summary from trial data ยท Aug 6, 2026 ยท Not medical advice
Belgium